Tobacco-Specific Carcinogenic Nitrosamines
- 1 May 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (9) , 1377-1384
- https://doi.org/10.1016/s0006-2952(97)00651-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell lineBrain Research, 1994
- Serotonin release and cell proliferation are under the control of α‐bungarotoxin‐sensitive nicotinic receptors in small‐cell lung carcinoma cell linesFEBS Letters, 1994
- Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans.Environmental Health Perspectives, 1993
- Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolitesCarcinogenesis: Integrative Cancer Research, 1993
- Nicotine and coronary heart diseaseTrends in Cardiovascular Medicine, 1991
- A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTXNeuron, 1990
- Investigations on the origin of tobacco-specific nitrosamines n mainstream smoke of cigarettesCarcinogenesis: Integrative Cancer Research, 1990
- Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosaminesBiochemical Pharmacology, 1989
- Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smokeCarcinogenesis: Integrative Cancer Research, 1988
- Absorption and metabolism of nicotine from cigarettes.BMJ, 1975